Kintuzumab(GenSci)

金妥利珠单抗(金赛药业)

Report date: 2026/04/21 20:00:18

Base Information

Drug NameKintuzumab(GenSci)
Drug Alias NameGentulizumab
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Cluster of differentiation 47
TargetsCluster of differentiation 47
Therapy Area/IndicationsSolid tumoursMyelodysplastic SyndromesHematologic Neoplasms +[6
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSolid tumoursMyelodysplastic SyndromesHematologic Neoplasms +[6

Other Information

ATC CodeN/A
Related LinksN/A